Skip to main content

. 1985 Jun 15;290(6484):1784–1785. doi: 10.1136/bmj.290.6484.1784-a

Torsade de pointes induced by sotalol despite therapeutic plasma sotalol concentrations.

R Krapf, M Gertsch

PMCID: PMC1415932 PMID: 3924255

1785

Images in this article

p1785-a
on p.1785

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Anttila M., Arstila M., Pfeffer M., Tikkanen R., Vallinkoski V., Sundquist H. Human pharmacokinetics of sotalol. Acta Pharmacol Toxicol (Copenh) 1976 Jul;39(1):118–128. doi: 10.1111/j.1600-0773.1976.tb03162.x. [DOI] [PubMed] [Google Scholar]
Brown H. C., Carruthers S. G., Kelly J. G., McDevitt D. G., Shanks R. G. Observations on the efficacy and pharmacokinetics of sotalol after oral administration. Eur J Clin Pharmacol. 1976 Mar 22;09(5-6):367–372. doi: 10.1007/BF00606550. [DOI] [PubMed] [Google Scholar]
Kuck K. H., Kunze K. P., Roewer N., Bleifeld W. Sotalol-induced torsade de pointes. Am Heart J. 1984 Jan;107(1):179–180. doi: 10.1016/0002-8703(84)90158-3. [DOI] [PubMed] [Google Scholar]
Laakso M., Pentikäinen P. J., Pyörälä K., Neuvonen P. J. Prolongation of the Q-T interval caused by sotalol--possible association with ventricular tachyarrhythmias. Eur Heart J. 1981 Aug;2(4):353–358. doi: 10.1093/oxfordjournals.eurheartj.a061216. [DOI] [PubMed] [Google Scholar]
Neuvonen P. J., Elonen E., Tanskanen A., Tuomilehto J. Sotalol and prolonged Q-Tc interval. Lancet. 1981 Aug 22;2(8243):426–426. doi: 10.1016/s0140-6736(81)90876-x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES